| Dr Evan Jay Pollack, MD | |
|
13701 E Mississippi Ave, Aurora, CO 80012-6141 | |
| (303) 689-0088 | |
| (303) 343-8011 |
| Full Name | Dr Evan Jay Pollack |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 13701 E Mississippi Ave, Aurora, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588669626 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 39611 (Colorado) | Primary |
| 208D00000X | General Practice | G56102 (California) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Evan Jay Pollack, MD 5749 S Geneva St, Greenwood Village, CO 80111-3728 Ph: (720) 489-4177 | Dr Evan Jay Pollack, MD 13701 E Mississippi Ave, Aurora, CO 80012-6141 Ph: (303) 689-0088 |
News Archive
Chemotherapy after surgery more than doubles survival rates for pancreatic cancer according to new research published today (18 March 2004) in the New England Journal of Medicine. Scientists from the University of Birmingham and the University of Liverpool have carried out a Europe wide study of more than 280 patients over 10 years.
The first study to compare survival between women with breast cancer whose treatment was based on consensus guidelines and those whose treatment was not shows that adhering to established guidelines improves survival and reduces the risk of recurrence.
During the life cycle of our cells, a minefield of environmental and biological assaults can lead to double-stranded DNA breaks, the most lethal and dangerous form of DNA damage. Now, in research published online this week in Nature, Rockefeller University scientists reveal that when these breaks occur, a protein called 53BP1 helps repair them by mobilizing their dangly DNA ends - findings that uncover a previously unknown aspect of how double-stranded breaks can get fixed.
Flexion Therapeutics, Inc., today reported that its lead compound FX006, a novel intra-articular, sustained release steroid, demonstrated pain relief that is of both greater magnitude and longer duration than the most commonly prescribed immediate release steroid, triamcinolone acetonide, in a Phase 2b dose-ranging trial in osteoarthritis.
› Verified 1 days ago
Judy W Christensen, General Practice Medicare: Not Enrolled in Medicare Practice Location: 2500 S Havana St, Aurora, CO 80014 Phone: 303-338-4434 | |
Edward D Bordas Jr, General Practice Medicare: Not Enrolled in Medicare Practice Location: 2500 S Havana St, Aurora, CO 80014 Phone: 303-338-4503 | |
Bola R Yafet, General Practice Medicare: Not Enrolled in Medicare Practice Location: 16601 E Centretech Pkwy, Aurora, CO 80011 Phone: 720-536-7933 | |
Dr. Jiaochen Ke, MD General Practice Medicare: Medicare Enrolled Practice Location: 1890 N Revere Ct Ste 4100, Aurora, CO 80045 Phone: 303-724-6021 | |
Sally J Sjobeck, General Practice Medicare: Not Enrolled in Medicare Practice Location: 2500 S Havana St, Aurora, CO 80014 Phone: 303-283-2813 | |
Beverly J Kruse, General Practice Medicare: Not Enrolled in Medicare Practice Location: 2500 S Havana St, Aurora, CO 80014 Phone: 303-338-3800 | |
Shakti Bachmann, PHARM.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 2500 S Havana St, Aurora, CO 80014 Phone: 303-743-5855 |